GEN - Genetic Engineering & Biotech NewsOriginal article
Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice
Phase 1positiveanti-CXCR3Positive
AI Analysis
Summary
Researchers demonstrated that an anti-CXCR3 antibody reduces T cell infiltration and limits neurodegeneration in a mouse model of Alzheimer's disease, resulting in improved brain tissue preservation and memory retention. This preclinical finding suggests a potential antibody-based therapeutic approach for tauopathies.
Clinical Trial Data
Phase
Preclinical
Primary Endpoint
Met
Outcome Details
Anti-CXCR3 treatment in mouse Alzheimer's model retained more brain tissue and showed better memory retention despite unchanged tau levels
Importance:3/10
Sentiment:
0.60
antibodyneurodegenerative diseaseAlzheimer's diseasetauopathypreclinicalCXCR3neuroinflammation
Read the original article
Published by GEN - Genetic Engineering & Biotech News on September 28, 2026 7:33 PM